Loading
GS
GB Sciences Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by POSS JOHN C, was filed 27 Jul 2018.
GB Sciences Inc: what insiders have been doing
GB Sciences Inc is a listed company. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of GB Sciences Inc in twelve months, the latest record being from 27 July 2018.
Looking back to 2016, when coverage begins, insiders filed 7 purchases and 33 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
40
Thresholds
n/a
Buy Volume
€34,743
7 ops. · all time
Sell Volume
€618,485
33 ops. · all time
Since the insiders bought
- -66.0%Entry US$0.34 · Close at T+365 US$0.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended March 2024 · cache
US$0.00
Analyst consensus
Income statement
EBITDA-US$1.1M
Net income-US$1.4M0.0% margin
Valuation
Beta10.91
Balance sheet & cash
Total debtUS$1.8M
Free Cash Flow-US$975.7k
Profitability & ownership
ROA-439.0%
% institutions0.0%
Last declaration on 27 July 2018
Declarations40 total
10,000 shares@ US$0.409.9% of flowCommon StockSEC:0001248996-18-000003:0
Canonical exit: 9 Oct 2018 (T+90)
23,184 shares@ US$0.4022.9% of flowCommon StockSEC:0001248996-18-000003:1
Canonical exit: 9 Oct 2018 (T+90)
30,000 shares@ US$0.40529.9% of flowCommon StockSEC:0001248996-18-000003:2
Canonical exit: 9 Oct 2018 (T+90)
1,250 shares@ US$0.4061.3% of flowCommon StockSEC:0001248996-18-000003:3
Canonical exit: 9 Oct 2018 (T+90)
20,000 shares@ US$0.4120.2% of flowCommon StockSEC:0001248996-18-000003:4
Canonical exit: 9 Oct 2018 (T+90)
3,615 shares@ US$0.4133.7% of flowCommon StockSEC:0001248996-18-000003:5
Canonical exit: 9 Oct 2018 (T+90)
11,915 shares@ US$0.41512.2% of flowCommon StockSEC:0001248996-18-000003:6
Canonical exit: 9 Oct 2018 (T+90)
50,000 shares@ US$0.2554.1% of flowCommon StockSEC:0000939798-17-000067:0
20,000 shares@ US$0.2551.6% of flowCommon StockSEC:0000939798-17-000067:1
30,000 shares@ US$0.2552.5% of flowCommon StockSEC:0000939798-17-000067:2
74,207 shares@ US$0.34829.4% of flowCommon StockSEC:0000939798-17-000055:0
25,793 shares@ US$0.34833.3% of flowCommon StockSEC:0000939798-17-000055:1
35,000 shares@ US$0.35774.5% of flowCommon StockSEC:0000939798-17-000055:2
65,000 shares@ US$0.34778.2% of flowCommon StockSEC:0000939798-17-000055:3
100,000 shares@ US$0.329212.0% of flowCommon StockSEC:0000939798-17-000055:4
25,000 shares@ US$0.3283.0% of flowCommon StockSEC:0000939798-17-000055:5
25,000 shares@ US$0.32833.0% of flowCommon StockSEC:0000939798-17-000055:7
50,000 shares@ US$0.32475.9% of flowCommon StockSEC:0000939798-17-000055:8
50,000 shares@ US$0.32915.9% of flowCommon StockSEC:0000939798-17-000055:9
11,810 shares@ US$0.32471.4% of flowCommon StockSEC:0000939798-17-000055:10
16,630 shares@ US$0.31311.9% of flowCommon StockSEC:0000939798-17-000055:11
10,800 shares@ US$0.3041.2% of flowCommon StockSEC:0000939798-17-000055:12
12,200 shares@ US$0.31141.3% of flowCommon StockSEC:0000939798-17-000055:13
21,500 shares@ US$0.33042.5% of flowCommon StockSEC:0000939798-17-000055:14
15,313 shares@ US$0.32011.8% of flowCommon StockSEC:0000939798-17-000055:15
25 of 40 declarations
About GB Sciences Inc
GB Sciences Inc is a company focused on developing cannabis and cannabinoid-based products. It emphasizes research and innovation in the life sciences sector.
